Showing results (161-170 of 337) with videos related to

Sort By:
Pageof 34
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 16, 2020
Targeted, Site-Specific, Delivery Vehicles of Therapeutics for COVID-19 Patients. Brief ReviewNicholas Kipshidze, Patrick Iversen, Thomas R Porter, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|September 6, 2018
Validation of a Gravitational Model to Study Local Endogenous Biomarkers in Chronic Venous InsufficiencyChristopher R Lattimer, Jawed Fareed, Debra Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 25, 2015
Fibrinolytic Dysregulation in Total Joint Arthroplasty Patients: Potential Clinical ImplicationsNil Guler, Andrew Burleson, Daneyal Syed, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 29, 2021
The Relationship Between Thrombo-Inflammatory Biomarkers and Cellular Indices of Inflammation in Lymphoma PatientsMark Jaradeh, Nausheen Baig, Emily Bontekoe, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 21, 2023
Glycemic Control and Plasma Levels of Pro-Inflammatory and Pro-Thrombotic Biomarkers in Diabetic Patients Presenting with Acute Pulmonary EmbolismAlexander O'Hara, Jacob Pozin, Amir Darki, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 23, 2021
Interrelationship of MMP-9, Proteoglycan-4, and Inflammation in Osteoarthritis Patients Undergoing Total Hip ArthroplastyHannah Slovacek, Rajan Khanna, Pavel Poredos, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 13, 2010
In vivo neutralization of unfractionated heparin and low-molecular-weight heparin by a novel salicylamide derivativeJacqueline Kuziej, Evangelos Litinas, Debra A Hoppensteadt, et al.
Seminars in Thrombosis and Hemostasis|April 16, 2004
Differentiation of low-molecular-weight heparins: impact on the future of the management of thrombosisJawed Fareed, Qing Ma, Michelle Florian, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 9, 2006
Modulatory effects of Escherichia coli capsular-derived sulfaminoheparosans and heparins on tissue factor-mediated activation of platelets: flow cytometric analysisJyothi Maddineni, Walter P Jeske, Francis Baltasar, et al.
International Angiology : a Journal of the International Union of Angiology|April 16, 2016
Effect of erythropoietin stimulating agents on vascular endothelial growth factor levels in patients with end stage renal diseaseJennifer L Saluk, Vinoid K Bansal, Debra A Hoppensteadt, et al.
Pageof 34